Nitric oxide prevents alveolar senescence and emphysema in a mouse model

8Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Nω-nitro-L-arginine methyl ester (L-NAME) treatment induces arteriosclerosis and vascular senescence. Here, we report that the systemic inhibition of nitric oxide (NO) production by L-NAME causes pulmonary emphysema. L-NAME-treated lungs exhibited both the structural (alveolar tissue destruction) and functional (increased compliance and reduced elastance) characteristics of emphysema development. Furthermore, we found that L-NAMEinduced emphysema could be attenuated through both genetic deficiency and pharmacological inhibition of plasminogen activator inhibitor-1 (PAI-1). Because PAI-1 is an important contributor to the development of senescence both in vitro and in vivo, we investigated whether L-NAME-induced senescence led to the observed emphysematous changes. We found that L-NAME treatment was associated with molecular and cellular evidence of premature senescence in mice, and that PAI-1 inhibition attenuated these increases. These findings indicate that NO serves to protect and defend lung tissue from physiological aging.

Cite

CITATION STYLE

APA

Boe, A. E., Eren, M., Morales-Nebreda, L., Murphy, S. B., Scott Budinger, G. R., Mutlu, G. M., … Vaughan, D. E. (2015). Nitric oxide prevents alveolar senescence and emphysema in a mouse model. PLoS ONE, 10(3). https://doi.org/10.1371/journal.pone.0116504

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free